Veritable, L.P.’s Abbott Laboratories Position
Does Veritable, L.P. own Abbott Laboratories (ABT)? Not currently — the last reported position was 101.7K shares worth $11M in Q2 2023; the fund’s latest 13F (Q3 2023) no longer reports it.
Position Value
$11M
Q2 2023
Shares
101.7K
% of Portfolio
+0.17%
Quarters Held
18
position exited
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2023 | 101.7K | $11M | +0.17% |
| Q1 2023 | 103.0K | $10M | +0.17% |
| Q4 2022 | 115.9K | $13M | +0.22% |
| Q3 2022 | 115.9K | $11M | +0.22% |
| Q2 2022 | 122.6K | $13M | +0.24% |
| Q1 2022 | 120.9K | $14M | +0.22% |
| Q4 2021 | 123.0K | $17M | +0.26% |
| Q3 2021 | 120.5K | $14M | +0.23% |
| Q2 2021 | 120.7K | $14M | +0.22% |
| Q1 2021 | 132.8K | $16M | +0.27% |
| Q4 2020 | 134.0K | $15M | +0.27% |
| Q3 2020 | 135.7K | $15M | +0.30% |
| Q2 2020 | 136.1K | $12M | +0.27% |
| Q1 2020 | 132.1K | $10M | +0.25% |
| Q4 2019 | 136.7K | $12M | +0.22% |
| Q3 2019 | 134.5K | $11M | +0.22% |
| Q2 2019 | 134.8K | $11M | +0.23% |
| Q1 2019 | 136.7K | $11M | +0.22% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Veritable, L.P.’s full portfolio or all institutional holders of ABT.